Amylyx Pharmaceuticals, Inc. financial statements, including revenue, expenses, profit, and loss
The total revenue of AMLX for the last quarter is 108.45 M USD, and it's 5.61% higher compared to the previous quarter. The net income of Q4 23 is 4.73 M USD.